2026-03-20 01:27:29
Multiple US-listed companies configure Bitcoin: ACXP approves $10 million purchase plan, ENFN plans to allocate 10% of cash
Biopharmaceutical company Acurx Pharmaceuticals approved a $10 million bitcoin purchase plan to hedge against R&D funding depreciation risks; Enfusion plans to invest 10% of excess cash in bitcoin and ethereum; Nature's Miracle launched a $5 million bitcoin reserve plan, demonstrating that cryptocurrencies are being incorporated into reserve assets. Meanwhile, demand for crypto custody services has grown 40%.